|
| Press Releases |
|
 |
|
| Tuesday, June 7, 2022 |
|
|
Novotech助力Endpoints ASCO 2022年專家組，加速中國腫瘤臨床試驗 |
| Novotech是亞太地區領先的生物技術臨床研究機構，近期入駐美國，助力Endpoints ASCO 2022年專家組，加速中國和美國臨床試驗進程。 more info >> |
|
|
Novotech助力Endpoints ASCO 2022年专家组，加速中国肿瘤临床试验 |
| Novotech是亚太地区领先的生物技术临床研究机构，近期入驻美国，助力Endpoints ASCO 2022年专家组，加速中国和美国临床试验进程。 more info >> |
|
| Monday, June 6, 2022 |
|
|
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China |
| Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 "Accelerating clinical development in China and the US". more info >> |
|
| Friday, June 3, 2022 |
|
|
노보텍, 초기 단계 종양학 임상 및 미-중 규제 전략에 관한 프리-ASCO 중국 서밋의 전문가 패널들을 후원 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상 시험수탁기관(CRO)인 노보텍(Novotech)은 중국과 미국의 종양학 약물 전문가가 참여하는 2022년 프리-ASCO 중국 서밋의 전문가 패널들을 후원했다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前中美早期腫瘤試驗和監管策略專家組 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其服務擴展到美國，在 2022 年 ASCO 前中國峰會上贊助了專家小組，匯集了中國和美國腫瘤藥物開發的領導者。 Pre-ASCO 系列在全球有超過 20,000 人觀看。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其服务扩展到美国，在 2022 年 ASCO 前中国峰会上赞助了专家小组，汇集了中国和美国肿瘤药物开发的领导者。 more info >> |
|
| Thursday, June 2, 2022 |
|
|
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US |
| Novotech, the leading Asia Pacific biotech specialist CRO with recently expanded services to the US, sponsored expert panels at the Pre-ASCO China Summit 2022, bringing together leaders in oncology drug development in China and the US. more info >> |
|
| Thursday, May 12, 2022 |
|
|
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정 |
| 최근 미국으로 서비스를 확장한 바 있는 아시아 태평양 지역 바이오테크 전문 임상시험수탁기관(CRO)인 노보텍(Novotech)은 '초기 단계 종양학 임상에 기반해 진행 여부 결정'이라는 제목의 2022년 프리-ASCO 중국 서밋(이하 '서밋')을 후원하게 된다. more info >> |
|
|
Novotech 贊助 ASCO 中國峰會前夕：基於早期腫瘤學試驗的 Go/No Go 決策 |
| Novotech 是亞太地區領先的生物技術專家 CRO，最近將其 CRO 服務擴展到美國，很高興贊助 2022 年 ASCO 中國峰會前活動，題為：基於早期腫瘤試驗的 Go/No Go Decisions（“峰會”）。 more info >> |
|
|
Novotech 赞助 ASCO 中国峰会前夕：基于早期肿瘤学试验的 Go/No Go 决策 |
| Novotech 是亚太地区领先的生物技术专家 CRO，最近将其 CRO 服务扩展到美国，很高兴赞助 2022 年 ASCO 中国峰会前活动，题为：基于早期肿瘤试验的 Go/No Go Decisions（“峰会”）。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
DK88 Casino Officially Launches in Malaysia
Feb 21, 2026 21:50 HKT/SGT
|
|
|
Graphene Manufacturing Group and Tickford Racing Unite to Push Performance Efficiency On and Off the Track
Feb 20, 2026 20:59 HKT/SGT
|
|
|
Full Convertible Bond Conversion Removes Overhang and Signals Valuation Reassessment for Shoucheng Holdings
Feb 20, 2026 20:32 JST
|
|
|
首程控股可轉債全額轉股落地 流動性釋放疊加獲利盤了結迎估值重塑
Feb 20, 2026 19:15 HKT/SGT
|
|
|
Investee Companies Take the National Stage: Shoucheng Holdings' 'Capital+Scenario+Industry Chain' Strategy Validated, Entering the Value Realization Phase
Feb 20, 2026 20:06 JST
|
|
|
首程控股可转债全额转股落地 流动性释放叠加获利盘了结迎估值重塑
Feb 20, 2026 18:43 HKT/SGT
|
|
|
春晚科技秀背后的布局者：首程控股绑定三大龙头 筑牢机器人生态壁垒
Feb 20, 2026 18:24 HKT/SGT
|
|
|
Hong Kong designer labels shine at London Fashion Week
Feb 20, 2026 17:04 HKT/SGT
|
|
|
Spritzer EcoPark Champions Inclusive Experiences in Nature Through Meaningful Community Engagement
Feb 20, 2026 15:37 HKT/SGT
|
|
|
Shoucheng Holdings Draws Focus After Portfolio Companies Appear in Spring Festival Gala Robotics Showcase
Feb 20, 2026 15:29 HKT/SGT
|
|
|
春晚科技秀背後的佈局者：首程控股綁定三大龍頭 築牢機器人生態壁壘
Feb 20, 2026 14:19 HKT/SGT
|
|
|
首程控股（0697.HK）機器人版圖閃耀2026春晚：投資回報步入爆發期
Feb 20, 2026 13:24 HKT/SGT
|
|
|
被投企業登上國家級舞台 首程控股「資本+場景+產業鏈」邏輯獲得驗證 進入價值兌現階段
Feb 20, 2026 12:57 HKT/SGT
|
|
|
被投企业登上国家级舞台 首程控股"资本+场景+产业链"逻辑获得验证 进入价值兑现阶段
Feb 20, 2026 12:57 HKT/SGT
|
|
|
Hitachi Rail Invests C$30 Million in New Canadian Headquarters
Feb 20, 2026 12:20 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
